MemorialCare, a California-based-based not-for-profit, integrated healthcare system, announced on Thursday that its Long Beach Medical Center, Orange Coast Medical Center, and Saddleback Medical Center have received multiple honours in the 2026 Women's Choice Awards.
This year, all MemorialCare hospitals were honoured in 10 different categories representing diverse clinical strengths.
Orange Coast Medical Center was named a Best Hospital for Patient Safety, Heart Care, Cancer Care, Bariatric Surgery, Obstetrics, Women's Services, Orthopedics, and Knee and Hip Replacement.
Saddleback Medical Center received distinctions as a Best Hospital for Patient Safety, Heart Care, Stroke Care, Minimally Invasive Surgery, Obstetrics, Orthopedics, and Knee and Hip Replacement.
Long Beach Medical Center was recognised as a Best Hospital for Heart Care, Stroke Care, and Cancer Care.
Eugene Kim, MD, chief medical officer of MemorialCare, commented: "This acknowledgement demonstrates that women trust us with their health, and that of their families. We honour that trust by providing the highest standard of care through ongoing innovation and high-quality care, while supporting patient empowerment and advocacy."
Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial
Day One completes Mersana acquisition to add rare cancer antibody drug conjugate
Cartography Biosciences partners with Pfizer to discover tumour-selective antigens
BostonGene and AstraZeneca collaborate to advance AI-driven oncology development
Abbott launches Libre Assist for in-the-moment food decisions
RedHill advances RHB-102 across GI indications
Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China
FDA grants priority review for Sanofi's Tzield in young children with stage 2 type 1 diabetes
Insilico Medicine signs multi-year research and development collaboration with Servier
Samsung Bioepis begins direct commercialisation of BYOOVIZ in Europe
MemorialCare hospitals recognised in 2026 Women's Choice Awards
International Isotopes Inc to change name to Radnostix Inc
Elanco Animal Health's Befrena (tirnovetmab) receives USDA approval for canine dermatitis